Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
Forget About 5G, China Says. We’re Already Developing 6G
Alibaba Sued by Home Appliance Maker Over E-Commerce Marketing
WeChat Pay Eyes Foreign Visitors in Race with Alipay
LATEST
Burberry to Work With Tencent to Open Social Retail Store in Shenzhen
JD.com Beats Estimates With 28% Revenue Growth in 3rd Quarter
Quantum Computing, CRISPR, Drones, Are Put on Chinese Kids’ Reading List
Reporter’s Notebook: Alibaba’s Good Luck Symbols Pay Off on Double 11
Money-Losing Ping An Fintech Unicorn Preparing for U.S. IPO
Hong Kong Unrest Rains on Trip.com’s Red Carpet
Internet Regulators Shut Down News Site for Defying Desist Order
Luckin Withdraws Lawsuit Against Starbucks As Sales Surge
Chinese Bitcoin-Mining Machine Company Canaan Slashes Its U.S. IPO
Alibaba CEO Strikes Hopeful Tone as E-Commerce Giant Prepares for Hong Kong IPO
WeWork’s China Challenger Eyes U.S. IPO Next Month
Chinese Podcast Startup Ximalaya Seeks $3.5 Billion Value
Weibo Reports 11.5% Drop in Third-Quarter Profit
China to Launch Vaccine-Tracing App Next Year: Report
Chinese Central Bank Denies Digital Currency Issuance Rumors
Chinese EV Maker Xpeng Secures $400 Million Series C Funding With Xiaomi Tie-up
China’s Starbucks Challenger Posts Piping Hot Third-Quarter Sales
Renowned Chinese Tech Veteran Harry Shum to Leave Microsoft
Two Billionaire Hikvision Directors Embroiled in Disclosure Investigation
Alibaba Eyes Nov. 26 Trading Debut for Hong Kong IPO
Genome Giant Denies Falsifying Revenue Data

By Wang Luyao and Tang Ziyi / Apr 09, 2019 12:22 PM / Business & Tech

Photo: VCG

Photo: VCG

Chinese genome giant BGI Genomics denies it falsified profit records after a securities regulator said the company had inflated its 2017 income by millions of yuan.

Shenzhen's Securities Regulatory Commission said the company exaggerated its project business income for 2017 by 13.3 million yuan ($1.98 million), and its net profit from its project business by 12.4 million yuan, according to a statement filed by BGI last week.

BGI said on Sunday that the revenue discrepancy was caused by “irregular” accounting standards and that the company has taken measures to update its data in accordance with regulations.

Related: Gene-Sequencer Illumina Faces Tough Competition as It Officially Enters China


Share this article
Open WeChat and scan the QR code